US7014655B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for conserving biological prostheses, conserved biological prostheses and conserving solutions
Assignee: Individual
•
Filing: 2001-12-03
•
Granted: 2006-03-21
•
Expires: 2021-12-03
Abstract
Abstract The invention concerns a method of conserving biological prostheses, wherein the method includes the following steps: (a) treating biological prostheses with a solution which contains a mixture of epoxide compounds which are at least in part of different lengths; (b) treating the biological prosthesis treated in accordance with step (a) with an antithrombotic-bearing solution; and (c) possibly storing the prosthesis treated in accordance with step (b) in a sterilising solution. The invention further concerns a biological prosthesis produced in accordance with the method of the invention and a conserving agent.
Inventors
- 👤 Leonid Barbarash
- 👤 Irina Jouravleva
- 👤 Svetlana Novikova
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 13:34
CPC Classifications
A; A61; A61L; A61L2/00; A61L2/16; A61L2/18; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61F2/2415
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
99 words
A conserved biological prosthesis produced in accordance with a method comprising the following steps: (a) treating a biological prosthesis with a solution which contains a mixture of epoxide compounds which are at least in part of different lengths, wherein said mixture of epoxide compounds includes at least one non-polymer epoxide compound with two epoxide groups; (b) treating the biological prosthesis treated in accordance with step (a) with a solution containing an antithrombotic, wherein the antithrombotic is a mixture of heparin and acetylsalicylic acid; and (c) optionally storing the prosthesis treated in accordance with step (b) in a sterilizing solution.
Claim 2
Dependent Claim
99 words
A conserved biological prosthesis produced in accordance with a method comprising the following steps: (a) treating a biological prosthesis with a solution which contains a mixture of epoxide compounds which are at least in part of different lengths, wherein said mixture of epoxide compounds includes at least one non-polymer epoxide compound with two epoxide groups; (b) treating the biological prosthesis treated in accordance with step (a) with a solution containing an antithrombotic, wherein the antithrombotic is a mixture of heparin and acetylsalicylic acid; and (c) optionally storing the prosthesis treated in accordance with step (b) in a sterilizing solution.
Claim 3
Dependent Claim
36 words
A conserved biological prosthesis as set forth in claim 1 wherein the biological prosthesis is selected from the group consisting of heart valves, artery segments, vein valves, valve-containing vein segments, and membranous tissues of a mammal.
Claim 4
Dependent Claim
18 words
The prosthesis as set forth is claim 2 wherein said prosthesis is a membranous tissue of a mammal.
Claim 5
Dependent Claim
18 words
The prosthesis as set forth in claim 3 wherein said membranous tissue is the pericardium of a mammal.
Claim 6
Dependent Claim
18 words
The prosthesis as set forth in claim 3 wherein said membranous tissue is the meninges of a mammal.
Claim 7
Dependent Claim
24 words
The prosthesis as set forth in claim 1 wherein the solution of step (a) contains a mixture of at least three different epoxide compounds.
Claim 8
Dependent Claim
59 words
The prosthesis as set forth in claim 1 wherein the mixture of epoxide compounds further includes at least one polymer epoxide compound with two or three epoxide groups and/or an epoxide compound with two or three epoxide groups, wherein arranged between at least two epoxide groups is a straight-chain or branched hydrocarbon chain with at least four carbon atoms.
Claim 9
Dependent Claim
26 words
The prosthesis as set forth in claim 1 wherein the mixture of epoxide compounds includes at least one epoxide compound with at least three epoxide groups.
Claim 10
Dependent Claim
19 words
The prosthesis as set forth in claim 1 wherein the epoxide group is a component of a glycidol residue.
Claim 11
Dependent Claim
35 words
The prosthesis as set forth in claim 1 wherein said at least one non-polymer epoxide compound is selected from the group which consists of alkylene glycol diglycidylethers, alkane diol diglycidylethers, polyalcohol diglycidylethers, and mixtures thereof.
Claim 12
Dependent Claim
21 words
The prosthesis as set forth in claim 10 wherein said at least one non-polymer epoxide compound is an alkylene glycol diglycidylether.
Claim 13
Dependent Claim
17 words
The prosthesis as set forth in claim 11 wherein said alkylene glycol diglycidylether is ethylene glycol diglycidylether.
Claim 14
Dependent Claim
21 words
The prosthesis as set forth in claim 10 wherein said at least one non-polymer epoxide compound is an alkane diol diglycidylether.
Claim 15
Dependent Claim
17 words
The prosthesis as set forth in claim 13 wherein said alkane diol diglycidylether is butane-1,4 diol diglycideylether.
Claim 16
Dependent Claim
20 words
The prosthesis as set forth in claim 10 wherein said at least one non-polymer epoxide compound is a polyalcohol diglycidylether.
Claim 17
Dependent Claim
15 words
The prosthesis as set forth in claim 15 wherein said polyalcohol diglycidylether is glycerine diglycidylether.
Claim 18
Dependent Claim
18 words
The prosthesis as set forth in claim 1 wherein the polymer epoxide compound is a polyalkylene glycol glycidylether.
Claim 19
Dependent Claim
32 words
The prosthesis as set forth in claim 17 wherein said polyakylene glycol glycidylether is selected from the group consisting of polyethylene glycol diglycidylether, polytetramethylene glycol glycidylether, polypropylene glycol diglycidylether, and mixtures thereof.
Claim 20
Dependent Claim
21 words
The prosthesis as set forth in claim 1 wherein the non-polymer epoxide compounds is/are alkane diol diglycidylether, and/or dicarboxylic acid diglycidylester.
Claim 21
Dependent Claim
15 words
The prosthesis as set forth in claim 19 wherein said non-polymer epoxide compound is hexane-1,6-diol-diglycidylether.
Claim 22
Dependent Claim
37 words
The prosthesis as set forth in claim 8 wherein the epoxide compounds with at least three epoxide groups are selected from the group which consists of polyalcohol polyglycidylethers, glycerine polyglycidylether, pentaerythrol polyglycidylether, polysaccharide polyglycidylether, and mixtures thereof.
Claim 23
Dependent Claim
22 words
The prosthesis as set forth in claim 21 wherein said epoxide compound with at least three epoxide groups is a polyalcolhol polyglycidylether.
Claim 24
Dependent Claim
15 words
The prosthesis as set forth in claim 22 wherein said polyalcohol polyglycidylether is sorbitol polyglycidylether.
Claim 25
Dependent Claim
37 words
The prosthesis as set forth in claim 1 wherein after the treatment in accordance with step (a) in step (b) the biological prosthesis is treated with a solution of heparin and acetylsalicylic acid without using additional reagents.
Claim 26
Dependent Claim
54 words
The prosthesis as set forth in claim 24 wherein after the treatment with heparin and acetylsalicylic acid in accordance with step (b) the biological prosthesis is rinsed in distilled water or an isotonic solution, in particular a 0.9% by weight NaCl solution, and then sterilized by treatment with a solution of an epoxide compound.
Claim 27
Dependent Claim
27 words
The prosthesis as set forth in claim 25 wherein the solution used for sterilization has a concentration of the epoxide compound of at least 2% by weight.
References Cited (Backward Citations)
US5080670A
Cited
US5165919A
Cited
WO1992009309A2
Cited
US5880242A
Cited
WO1997032472A1
Cited
WO1998046288A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2009-03-20 | 2009-09-19 | 2010-03-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2013-03-20 | 2013-09-19 | 2014-03-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2017-03-20 | 2017-09-19 | 2018-03-21 | $7700.00 | Window Closed / Lapsed |